India, Aug. 5 -- While reporting financial results for the second quarter on Wednesday, Elanco Animal Health, Inc. (ELAN) initiated its adjusted earnings and revenue guidance for the third quarter, and raised its outlook for the full-year 2026, based on strong second quarter performance.
For the third quarter, the company expects adjusted earnings in a range of $0.19 to $0.22 per share on revenues between $1.195 billion and $1.220 billion, with organic constant currency revenue growth of 5 to 7 percent.
Looking ahead to fiscal 2026, the company now projects adjusted earnings in a range of $1.10 to $1.16 per share on revenues between $5.09 billion and $5.14 billion, with organic constant currency revenue growth of 6 to 7 percent.
Previous...